Skye Bioscience, Inc. — Director's Dealing 2018

Dec 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2018-12-27

Reporting Person: Emerald Health Sciences Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-27	Common Stock	J	37667	—	Acquired	73153917	Direct

Footnotes

F1: The shares were issued pursuant to the conversion of accrued and unpaid interest on a convertible note, which is no longer outstanding, at the conversion price of $.10 per share.